Motif Bio Share Discussion Threads

[timbo003] 17/7/2015 22:50

>>>>hazl
Woodford is not involved here, but his old employer (Invesco) is.
Link to major shareholders (June 23rd) now added to the header (and also copied below)



>>>>ProactiveST
Thanks for the link to the interview, now added to the header

[proactivest] 17/7/2015 15:39

Interview with CEO Lumsden


The chief executive of Motif Bio (LON:MTFB), Graham Lumsden, says the company is looking to get Phase III trials for its antibiotic drug Iclaprim up and running as quickly as possible.

Today the firm told investors that American regulator the Food & Drug Administration (FDA) has given Iclaprim qualified infectious diseases product (QIPD) status.

This makes Iclaprim eligible for certain incentives, including priority review and fast track designation.

[proactivest] 17/7/2015 15:38

Interview with CEO Lumsden


The chief executive of Motif Bio (LON:MTFB), Graham Lumsden, says the company is looking to get Phase III trials for its antibiotic drug Iclaprim up and running as quickly as possible.

Today the firm told investors that American regulator the Food & Drug Administration (FDA) has given Iclaprim qualified infectious diseases product (QIPD) status.

This makes Iclaprim eligible for certain incentives, including priority review and fast track designation.

[hazl] 17/7/2015 12:26

Edit

Invesco has backed this, see post 436 thanks timbo for pointing out my error.

[hazl] 17/7/2015 11:30

Have got back in here today.
I think they are working just in the right field so next week sho uld be interesting!

[regandharry5] 17/7/2015 08:44

With FDA approval does anybody think dual listing would be a move to consider?.

[regandharry5] 17/7/2015 07:41

Yess, Onwards and upwards.

[timbo003] 17/7/2015 07:41

All things considered that is very good news, it could have been a bit better had Motif got QIDP designation for both indications, but I will settle for one for now.

So that's 10 years exclusivity (instead of the normal 5) for the pneumonia (HABP)indication, but we have to wait a few days to have that confirmed for the second skin (ABSSSI) indication.

Assuming we get this, the placing then goes through and that is all the short term funding worries over.

[regandharry5] 15/7/2015 17:15

Could be, RNS says no later than the 24th, but obviously it could be sooner.

[timbo003] 15/7/2015 13:40

The placing will occur if and when Motif get QIDP designation for iclaprim.

Should this occur in the next week or so (as expected), then it is extremely significant news and I doubt if there will be many placees selling at around the current price.

[timbo003] 15/7/2015 13:30

Despite earlier predictions of share price Armageddon with the placing, the shares are doing rather well. Trying to predict short term share price movements, is a bit like trying to predict red or black at the casino, I don't know why some investors are so keen to do it so publicly.

[victor2] 15/7/2015 12:51

Shares started to move up could there be an early
announcement re QIDP ?

[regandharry5] 10/7/2015 18:02

Squeaky bum time till the 24th July?

[a1samu] 10/7/2015 15:44

RNS Number : 7677S

10 July 2015

Result of General Meeting

Motif Bio plc, the clinical stage biopharmaceutical company specialising in developing novel antibiotics, is pleased to announce that at the General Meeting held earlier today all resolutions as set out in the Notice of General Meeting annexed to the circular to shareholders dated 23 June 2015 were duly passed. The passing of the resolutions represents the satisfaction of the first of the two conditions to completion of the conditional placing of 44,000,000 ordinary shares announced by the Company on 23 June 2015.

The second condition, being the successful grant of the QIDP (qualified infections disease product) designation for iclaprim in the US (such grant not to be later than 24 July 2015), remains to be satisfied.

What are the chances this is going to happen by the 24 July 2015? I wonder whether the company already has the nod that this will happen in any case, for surely it would be inconceivable that they would announce the fund raising without having an indication that this QIDP will be forthcoming?

[scott1000] 09/7/2015 10:07

The placing shares have up until the. 31st July to be released to the market, so people are most likely holding off until after the placing shares.. As this could bounce down near the 50p mark.. I fully expect news to flow after the placing, and for this to get back on track. The next month in my opinion will be steady.. But a great mid/long term investment here

[baldrick1] 09/7/2015 08:40

Why is the share price falling?is it because of the placing price of 50p is now out to market?could anyone explain?

[bad robot] 07/7/2015 13:47

We are due the mega bounce to 120p


Hope this helps

[regandharry5] 04/7/2015 12:39

Interesting article but again I wonder why there is no reference to the RNS of the 1st June regarding the involvement of a new Large pharma as a CRO.

Don't feel people are getting all the info if these articles leave out important parts of the story.

[regandharry5] 03/7/2015 10:31

So the shares that were placed at 50p are going to be sold to the MMs, and they are then going to sell them back to PI's for 50p

[baldrick1] 02/7/2015 10:36

Not long now for the 50p placing to hit the market.No wonder peeps are now taking their profits and then buy back at 50p

[baldrick1] 26/6/2015 10:20

36 months? Aim traders don't wait that long imho